Table 2 Basic information
From: The effect of loteprednol suspension eye drops after corneal transplantation
Prednisolone acetate group (n = 35) | Loteprednol group (n = 27) | P value | |
|---|---|---|---|
Age (years) | 53.21 ± 11.44 | 53.75 ± 15.37 | 0.874 |
Male, n (%) | 17 (48.57) | 22 (81.48) | 0.973 |
Surgical method, n (%) | 0.746 | ||
PKP | 22 (62.86) | 16 (59.26) | |
LKP | 13 (34.14) | 11 (40.74) | |
High risk keratoplasty | 5 (14.29) | 4 (14.81) | 0.953 |
Graft bed size > 8.5mm | 3 (8.57) | 2 (7.41) | |
Eccentric graft bed | 2 (5.71) | 2 (7.41) | |
Preoperative diagnosis, n (%) | 0.225 | ||
Leukoma | 12 (34.29) | 6 (22.22) | |
Cornea dystrophy | 4 (11.43) | 2 (7.41) | |
Corneal degeneration | 1 (2.85) | 2 (7.41) | |
Keratoconus | 3 (8.57) | 1 (3.70) | |
Infectious corneal ulcer | 12 (34.29) | 13 (48.15) | |
Infective corneal perforation | 3 (8.57) | 3 (11.11) |